131 studies found for:    "Arthritis, Juvenile Rheumatoid"
Show Display Options
Rank Status Study
21 Completed Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: meloxicam oral suspension;   Drug: naproxen oral suspension
22 Not yet recruiting Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
Condition: Juvenile Idiopathic Arthritis
Intervention:
23 Not yet recruiting Identification of Genes Involved in Juvenile Idiopathic Arthritis by Wholel Exome Sequencing
Condition: Arthritis, Juvenile Rheumatoid
Intervention: Biological: Blood sample
24 Recruiting Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Genetic: Blood test
25 Terminated Single Patient Use of Tocilizumab in Systemic Onset Juvenile Idiopathic Arthritis
Conditions: Arthritis, Juvenile Rheumatoid;   Still's Disease, Juvenile Onset
Intervention: Biological: tocilizumab
26 Unknown  Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention:
27 Completed Effect of Whole Body Vibration Therapy in Children With Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Intervention: Device: Galileo (whole body vibration (WBV) therapy)
28 Completed A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA)
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: meloxicam 0.25 mg/kg;   Drug: meloxicam 0.125 mg/kg;   Drug: naproxen 10 mg/kg
29 Active, not recruiting Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis
Conditions: Uveitis;   Juvenile Arthritis
Interventions: Drug: Anti-tumor necrosis factor alpha monoclonal antibody;   Drug: placebo
30 Terminated
Has Results
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab;   Drug: Placebo
31 Unknown  Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis
Condition: Juvenile Idiopathic Arthritis
Interventions: Drug: Infliximab plus methotrexate;   Drug: Combination of DMARDs;   Drug: Methotrexate alone
32 Completed A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib;   Drug: Naproxen
33 Terminated
Has Results
Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis
Condition: Arthritis, Juvenile Rheumatoid
Interventions: Drug: Celecoxib;   Drug: nsNSAIDs
34 Recruiting An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever.
Condition: Systemic Juvenile Idiopathic Arthritis
Intervention: Drug: Canakinumab
35 Completed Interleukin-1 Receptor Antagonist (IL-1RA) (ANAKINRA) IN SEVERE SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
Condition: Systemic-Onset Juvenile Idiopathic Arthritis
Interventions: Drug: Anakinra;   Biological: Pneumo23
36 Not yet recruiting An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis
Interventions: Drug: Canakinumab - Cohort 1;   Drug: Canakinumab - Cohort 2
37 Completed
Has Results
Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
Condition: Systemic Juvenile Idiopathic Arthritis With Active Flare
Interventions: Drug: canakinumab;   Drug: placebo
38 Completed TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis
Conditions: Juvenile Rheumatoid Arthritis;   Uveitis
Intervention: Drug: Enbrel
39 Terminated Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
Condition: Juvenile Rheumatoid Arthritis
Interventions: Drug: Enbrel;   Drug: Placebo
40 Completed
Has Results
Jointstrong Intervention for Juvenile Arthritis
Condition: Juvenile Arthritis
Interventions: Behavioral: CD-ROM;   Behavioral: Wait-list Control Group

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years